FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3127745302> ?p ?o ?g. }

• W3127745302 endingPage "345" @default.
• W3127745302 startingPage "339" @default.
• W3127745302 abstract "Summary Patients with chronic lymphocytic leukaemia (CLL) have an increased risk of new malignancies. However, limited data have been published about the impact of CLL treatment on this risk. Here we followed a Danish population‐based cohort of CLL patients for risks of new malignancies. Patients in the Danish CLL registry (2008–2017) were included. Up to 50 CLL‐free matched comparators were identified. First‐line treatment was categorized into four groups; bendamustine, chlorambucil, fludarabine or other. Patients were followed from CLL diagnosis for individual types of malignancy. Adjusted hazard ratios (HR) for new malignancies and 95% confidence intervals (95% CI) were calculated. Overall, 4286 CLL patients and 214 150 controls developed 594 and 20 565 new malignancies respectively. Risk of new malignancies was increased for CLL patients. Chemotherapy treatment was registered for 1064 (25%) patients with CLL. Chemotherapy was associated with increased HR (1·51, 95% CI: 1·3–1·8) of any new malignancy. Specifically, fludarabine was associated with an increased risk of myelodysplastic syndrome (MDS) (HR 4·93, 95% CI: 1·2–19·8). Patients with CLL are at increased risk of other haematological and solid malignancies compared to the general population. Chemotherapy exposure is associated with increased risk of second malignancies and fludarabine is associated with increased risk of MDS." @default.
• W3127745302 created "2021-02-15" @default.
• W3127745302 creator A5008481807 @default.
• W3127745302 creator A5011876375 @default.
• W3127745302 creator A5023096734 @default.
• W3127745302 creator A5024356923 @default.
• W3127745302 creator A5031331400 @default.
• W3127745302 creator A5036248073 @default.
• W3127745302 creator A5057884204 @default.
• W3127745302 creator A5090277454 @default.
• W3127745302 date "2021-02-11" @default.
• W3127745302 modified "2023-10-14" @default.
• W3127745302 title "Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population‐based study" @default.
• W3127745302 cites W1966444756 @default.
• W3127745302 cites W1977208315 @default.
• W3127745302 cites W2007961774 @default.
• W3127745302 cites W2027703570 @default.
• W3127745302 cites W2062956658 @default.
• W3127745302 cites W2069162303 @default.
• W3127745302 cites W2080337468 @default.
• W3127745302 cites W2092224069 @default.
• W3127745302 cites W2135216058 @default.
• W3127745302 cites W2160208506 @default.
• W3127745302 cites W2219591537 @default.
• W3127745302 cites W2337485820 @default.
• W3127745302 cites W2396328865 @default.
• W3127745302 cites W2544982242 @default.
• W3127745302 cites W2884831478 @default.
• W3127745302 cites W2887384183 @default.
• W3127745302 cites W2948436219 @default.
• W3127745302 cites W2975733352 @default.
• W3127745302 cites W2978400255 @default.
• W3127745302 cites W3010820109 @default.
• W3127745302 cites W3040916347 @default.
• W3127745302 cites W3044998544 @default.
• W3127745302 doi "https://doi.org/10.1111/bjh.17337" @default.
• W3127745302 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33570184" @default.
• W3127745302 hasPublicationYear "2021" @default.
• W3127745302 type Work @default.
• W3127745302 sameAs 3127745302 @default.
• W3127745302 citedByCount "11" @default.
• W3127745302 countsByYear W31277453022021 @default.
• W3127745302 countsByYear W31277453022022 @default.
• W3127745302 countsByYear W31277453022023 @default.
• W3127745302 crossrefType "journal-article" @default.
• W3127745302 hasAuthorship W3127745302A5008481807 @default.
• W3127745302 hasAuthorship W3127745302A5011876375 @default.
• W3127745302 hasAuthorship W3127745302A5023096734 @default.
• W3127745302 hasAuthorship W3127745302A5024356923 @default.
• W3127745302 hasAuthorship W3127745302A5031331400 @default.
• W3127745302 hasAuthorship W3127745302A5036248073 @default.
• W3127745302 hasAuthorship W3127745302A5057884204 @default.
• W3127745302 hasAuthorship W3127745302A5090277454 @default.
• W3127745302 hasBestOaLocation W31277453022 @default.
• W3127745302 hasConcept C126322002 @default.
• W3127745302 hasConcept C143998085 @default.
• W3127745302 hasConcept C207103383 @default.
• W3127745302 hasConcept C2776694085 @default.
• W3127745302 hasConcept C2776755627 @default.
• W3127745302 hasConcept C2777866208 @default.
• W3127745302 hasConcept C2777938653 @default.
• W3127745302 hasConcept C2778461978 @default.
• W3127745302 hasConcept C2779263901 @default.
• W3127745302 hasConcept C2781442060 @default.
• W3127745302 hasConcept C2908647359 @default.
• W3127745302 hasConcept C44249647 @default.
• W3127745302 hasConcept C50382708 @default.
• W3127745302 hasConcept C71924100 @default.
• W3127745302 hasConcept C99454951 @default.
• W3127745302 hasConceptScore W3127745302C126322002 @default.
• W3127745302 hasConceptScore W3127745302C143998085 @default.
• W3127745302 hasConceptScore W3127745302C207103383 @default.
• W3127745302 hasConceptScore W3127745302C2776694085 @default.
• W3127745302 hasConceptScore W3127745302C2776755627 @default.
• W3127745302 hasConceptScore W3127745302C2777866208 @default.
• W3127745302 hasConceptScore W3127745302C2777938653 @default.
• W3127745302 hasConceptScore W3127745302C2778461978 @default.
• W3127745302 hasConceptScore W3127745302C2779263901 @default.
• W3127745302 hasConceptScore W3127745302C2781442060 @default.
• W3127745302 hasConceptScore W3127745302C2908647359 @default.
• W3127745302 hasConceptScore W3127745302C44249647 @default.
• W3127745302 hasConceptScore W3127745302C50382708 @default.
• W3127745302 hasConceptScore W3127745302C71924100 @default.
• W3127745302 hasConceptScore W3127745302C99454951 @default.
• W3127745302 hasFunder F4320325957 @default.
• W3127745302 hasIssue "2" @default.
• W3127745302 hasLocation W31277453021 @default.
• W3127745302 hasLocation W31277453022 @default.
• W3127745302 hasOpenAccess W3127745302 @default.
• W3127745302 hasPrimaryLocation W31277453021 @default.
• W3127745302 hasRelatedWork W1998954504 @default.
• W3127745302 hasRelatedWork W2023984538 @default.
• W3127745302 hasRelatedWork W2067030170 @default.
• W3127745302 hasRelatedWork W2114753349 @default.
• W3127745302 hasRelatedWork W2163348695 @default.
• W3127745302 hasRelatedWork W2247136531 @default.
• W3127745302 hasRelatedWork W2326175431 @default.
• W3127745302 hasRelatedWork W2419406204 @default.

• next